QURE

uniQure N.V. Ordinary Shares (QURE)

About uniQure N.V. Ordinary Shares (QURE)

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.

Details

Daily high

$17.57

Daily low

$15.35

Price at open

$15.58

52 Week High

$17.71

52 Week Low

$3.73

Market cap

827.7M

Dividend yield

0.00%

Volume

2.1M

Avg. volume

4.9M

P/E ratio

-3.43

uniQure N.V. Ordinary Shares News